ReviewNature reviews. Cardiology2020
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control.
Martin R Cowie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
413 papers cite itlatest 60 shown
this paperpooled ittrialcites it